DAWN Day One Biopharmaceuticals, Inc. Common Stock PHARMACEUTICAL PREPARATIONS Best Pharmaceutical Stocks 2026 →

Day One Biopharmaceuticals (DAWN) Stock: Buy, Sell, or Hold?

$21.53
+0.04 (+0.19%) ▲
5d: +0.28% 30d: +0.8% 90d: +78.38%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (68%)
Quality Score
51/100
Position
FAIR
Forward P/E & Valuation
-504.2x CHEAP
vs 73.7x historical avg
Wall Street Target
$21.50
-0.1% vs target
Options IV & Volume
UNKNOWN Vol
UNKNOWN volume confirmation
Support / Resistance
$21.45 / $21.53
Trend: Strong Uptrend
💡Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
â„šī¸ NEUTRAL: DAWN is fairly priced but lacks strong directional signals. At 0% expected growth, valuation appears cheap. Wait for clearer setup or better entry on dips.

Get Alerted When DAWN Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

In-depth Analysis How we analyze

Valuation Analysis: DAWN is currently trading at $21.53, which is considered fair based on recent price action. From a valuation perspective, the stock is trading at a discount (Forward PE: -504.2) compared to its historical average (73.7). At these levels, the market is pricing in 0% annual earnings growth. This growth rate appears achievable given the company's track record, suggesting the valuation is rational.

Technical Outlook: Technically, DAWN is in a strong uptrend. The price is currently testing key support at $21.45. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock scores a mixed 40/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Current signals suggest waiting for a better entry point before initiating new positions.

Quick Decision Summary

Current Position FAIR
Company Quality Score 51/100 (HOLD)
Volume Confirmation UNKNOWN
Confidence Score 67.6%

Trading Range & Key Levels

Support Level $21.45
Resistance Level $21.53
Current Trend Strong Uptrend
Technical data as of Apr 22, 2026

Protect Your Profits

DAWN is technically overbought (RSI 80). Consider hedging now to protect against a potential pullback while keeping your upside.

View Profit Protection Plan

Quantitative Signal Breakdown

  • NEUTRAL: Price in fair range
  • NEUTRAL: Mixed technical signals (40/100)
  • NEUTRAL: Near Wall St target ($21.50)
  • BULLISH: Market expects only 0% annual growth - appears undervalued
  • WARNING: Composite score 51/100 in the bottom quintile — this cohort historically lags the market

Fundamental Context

Forward P/E (Next Year Est.) -504.22
Wall Street Target $21.50 (-0.1%)
Revenue Growth (YoY) 83.9%
Profit Margin -67.8%
PE vs Historical -504.2 vs 73.7 CHEAP
Share DAWN Analysis

Share this live DAWN analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.

bloggers & journalists: you are free to use our charts with attribution.

Reddit & Retail Trader Sentiment (DAWN)

Bullish 2 Retail Mentions
Reddit / WSB Comments
1
Bullish
StockTwits Volume
1 msgs
24h retail stream
Last Tracked
Oct 14, 2026
Daily AI digest
AI Retail Discussion Summary: A bullish sentiment is prevailing on StockTwits regarding $DAWN, with traders expressing optimism about recent news surrounding $RADX and Day One. No recent news articles are available.
Key Retail Themes: $RADX news Day One acquisition
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams. View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:59 AM ET
Data refreshes hourly during market hours. Next update: 2:59 AM
đŸ”Ĩ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL

Unlock Insider Activity

See real-time buying/selling by company executives for DAWN.

Create Free Account

Already have an account? Log In

Top Rated Biotechnology Stocks

Top-rated stocks in Biotechnology by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
KYMR
Kymera Therapeutics Inc
STRONG BUY
24 analysts
$145 31 SELL
ARGX
argenx NV ADR
STRONG BUY
23 analysts
$1147 35 SELL
BNTX
BioNTech SE
BUY
21 analysts
$114 62 BUY
IRD
Opus Genetics, Inc.
STRONG BUY
18 analysts
$13 41 HOLD
MRUS
Merus BV
STRONG BUY
17 analysts
$97 39 SELL

Advanced DAWN Option Strategies

Professional options setups generated by AI based on today's DAWN price and gamma walls.

Iron Condor Bull Call Bear Put Collar

Explore More Analysis & Live Quant Tools

Part A: Deep-Dive DAWN Research Pages
DAWN Technical Chart DAWN Price Prediction DAWN Intrinsic Value DCF DAWN Earnings Date DAWN Investment Advisor DAWN Fair Price Analyzer DAWN Options Chain DAWN Options Advisor DAWN Options Analysis DAWN Competitors
Part B: Tradestie Flagship Market Scanners
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals